Tagged with List

The 2021 WHO Essential Medicines List: How Pharma Can Turn Challenge into Opportunity

Global The 2021 WHO Essential Medicines List: How Pharma Can Turn Challenge into Opportunity

Global Shawview Consulting’s Brendan Shaw examines the WHO’s recently released updated Essential Medicines List. Shaw highlights some of the key trends and new inclusions in the List, why pricing and transparency are hotter topics than ever, and how pharma can incorporate this important document and its implications into their strategies for…

Top 20 Pharma Companies in France Ranking

Pharma Top 20 Pharma Companies in France Ranking

Pharma The following chart shows the top 20 pharma companies in France, ranked by sales for the year 2015. Global giant Novartis leads the way, followed by national champion Sanofi, and American titan Pfizer. Click here to read more articles and interviews from France, and to download the latest free pharma…

Interview: Eric Placet – CEO, CreaPharm Group, France

Pharma Interview: Eric Placet – CEO, CreaPharm Group, France

Pharma CreaPharm Group’s CEO, Eric Placet, discusses the creation of his company, ambitions for growth, and the lessons learned throughout his leadership. He also emphasizes the relevance of the size of the business in optimizing performance. For the last 20 years, you have built the CreaPharm Group to the success that…

Top 100 Pharma Companies Ranking in Turkey

Pharma Top 100 Pharma Companies Ranking in Turkey

Pharma Below is a list of the Top 100 Pharma Companies in Turkey sorted by the total value of sales in USD for 2014. Global giant Novartis is number one in a market worth a total of more than seven billion dollars. Source: IMS Health Click here to read more articles and…

Top Pharma Facilities in Puerto Rico

Puerto Rico Top Pharma Facilities in Puerto Rico

Puerto Rico Click here to read more articles and interviews from Puerto Rico, and to download the latest free pharma report on the country.

Mario Piccinin and Lara Iob, Life Science Partners, Ernst & Young Canada

Ernst & Young LLP Mario Piccinin and Lara Iob, Life Science Partners, Ernst & Young Canada

Ernst & Young LLP Mario Piccinin and Lara Iob of EY Canada discuss some of the key trends of the country’s biotech industry and the affiliate’s dedication to helping clients navigate the SR&ED tax credit process available in Canada. What do you see as the biggest challenges of life sciences clients in…

Other Topics

India

M&A

European Biotech

Cell & Gene Therapy

R&D Section Page